ILP-101

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameILP-101
Drug Alias NameILP-101ILP101
ClassificationCell and gene therapy > Gene therapyBiologics > Live Biotherapeutic
Mechanisms of ActionC-X-C motif chemokine 17 gene transference
TargetsC-X-C motif chemokine 17
Therapy Area/IndicationsType I InterferonopathiesCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIlya Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesIlya Pharma AB
Inactive CompaniesN/A
Active IndicationsType I InterferonopathiesCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A